Medical Director (Medical Advisor) - Netherlands/Belgium/Sweden - Sponsor-dedicated
Syneos Health
Medical Director (Medical Advisor) - Netherlands/Belgium/Sweden - Sponsor-dedicated
A Medical Director (Medical Advisor) is needed for a sponsor-dedicated role at Syneos Health for an 8-month contract. The position provides medical oversight for clinical studies, interacts with senior management and customers, and ensures subject safety and scientific integrity. The role is remote, based in the Netherlands/Belgium/Sweden, and requires experience in drug development and FDA/GCP regulations.
Medical Director (Medical Advisor) - Netherlands/Belgium/Sweden - Sponsor-dedicated
A Medical Director (Medical Advisor) is needed for a sponsor-dedicated role at Syneos Health for an 8-month contract. The position provides medical oversight for clinical studies, interacts with senior management and customers, and ensures subject safety and scientific integrity. The role is remote, based in the Netherlands/Belgium/Sweden, and requires experience in drug development and FDA/GCP regulations.
Salary
Core Qualifications
Technical (Must-have)
Soft Skills
Key Responsibilities
- Provides medical oversight of assigned clinical studies as a medical monitor.
- Provides medical input and oversight in support of Drug Safety and Pharmacovigilance.
- Responsible for protocol design and development, and input into protocol amendments.
- Develops and delivers project-specific and therapeutic training to project team and clinical site staff.
- Provides medical and therapeutic input to Study Start Up, Feasibility, and Subject Identification efforts.
- Provides medical input into data collection tools, monitoring plans, and review and analysis plans.
- Oversees Medical Scientist staff and Medical Director colleagues in clinical data review.
- Provides after-hours medical coverage for clinical studies.
- Adheres to enterprise policies, SOPs, and project plans.
- Maintains knowledge of FDA and worldwide drug development regulations and ICH GCP guidelines.